Corindus to Unveil CorPath(TM) its Remote Controlled Angioplasty System at TCT 2006.AUBURNDALE, Mass. -- Corindus, developer and marker of proprietary remote control catheterization catheterization Threading of a flexible tube (catheter) through a channel in the body to inject drugs or a contrast medium, measure and record flow and pressures, inspect structures, take samples, diagnose disorders, or clear blockages. systems, announced today that it will unveil CorPath(TM) in the emerging technologies area at the Cardiovascular Research Foundation's (CRF CRF abbr. chronic renal failure CRF Chronic renal failure ) eighteenth annual Transcatheter Cardiovascular Therapeutics (TCT TCT The Capital Times (Madison, WI newspaper) TCT Transcatheter Cardiovascular Therapeutics TCT The Coroner's Toolkit TCT Trans Canada Trail TCT Tcl Core Team TCT Tsukuba College of Technology (Japan) ) scientific symposium in Washington, D.C. Corindus teamed up with Simbionix, a global leader in medical simulation technology, to offer live simulated cases using CorPath(TM). Tal Wenderow, Corindus' CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , said "Physicians will have an opportunity to test CorPath(TM). Corindus will use Simbionix's latest medical angioplasty simulation system, the new ANGIO-Mentor(TM) mini, to allow physicians to experience angioplasty procedures using CorPath(TM)." "CorPath(TM) allows physicians to perform endovascular procedures from a safe distance, diminishing their exposure to harmful X-ray radiation and the need to wear leaded garments," explained Wenderow. The CorPath(TM) system should help alleviate orthopedic injuries that are frequently reported from wearing leaded apparel. Wenderow said that one of the CorPath(TM) Investigators had to undergo cervical surgery this year after years of wearing leaded aprons. "Over time, the cumulative effects of radiation can be damaging, but so can years of wearing protective garments that can lead to neck and back problems." Corindus will host CorPath(TM) simulated angioplasty cases from October 23rd through the 25th during morning and afternoon sessions. The live demonstrations will take place at Corindus' booth # 447. For more information on this unique opportunity visit Corindus on the web at http://corindus.com/news36.doc or email Corindus at TCT2006@corindus.com or by calling 617-581-6210. About Corindus Corindus designs, manufactures and commercializes patented remote control systems for interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based . Its CorPath(TM) system enables the physician to perform catheterization procedures from a remote location beyond the radiation zone. Compatible with state-of-the-art cardiology cardiology Medical specialty dealing with heart diseases and disorders. It began with the 1749 publication by Jean Baptiste de Sénac of contemporary knowledge of the heart. Diagnostic methods improved in the 19th century, and in 1905 the electrocardiograph was invented. products and cath lab A catheterization laboratory or cath lab is an examination room in a hospital or clinic with diagnostic imaging equipment to support the catheterization procedure. A catheter is inserted into a large artery, and various wires and devices can be inserted through the body via imaging technologies, CorPath(TM) mechanically maneuvers devices through patients' arteries as specified by the physician at a remote workstation. The proprietary technology utilizes physician fluoroscopic Fluoroscopic (fluoroscopy) An x-ray procedure that produces immediate images and motion on a screen. The images look like those seen at airport baggage security stations. Mentioned in: Hypotonic Duodenography control similar to routine practice to allow maneuvering and torquing of cath lab devices. Initial clinical trials have demonstrated CorPath's safety and efficacy. Unique to CorPath(TM) is the simplicity of integration into existing cath lab systems. The CorPath[TM] system requires regulatory clearance and currently is used for investigational purposes only. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion